Diamonds and Dogs


Big Blue flexing its muscle lifting the Dow. IBM is up 8% to a five month high following earning. The company beat earnings estimates by 2 cents as revenue came in higher than expectations thanks to strong cloud revenue which rose 20%. IBM also modestly raises earnings expectations and received a couple upgrades. One analyst believes IBM will parlay their cyclical benefits into secular tailwinds in 2018 to drive sustained revenue.

Drug maker, Allergan (AGN) is down 3% and down 7% in the last two days to a 10 month low on news a U.S. judge on Monday essentially invalidated Allergan's move to transfer their blockbuster dry-eye medicine drug, Restasis patent to the New York state's Saint Regis Mohawk Tribe, claiming the group's status as a sovereign nation meant the patents could not be reviewed by the U.S. patent office. A creative move by Allergan, but it looks like our courts won't let it pass.  

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.